Trials / Completed
CompletedNCT00913783
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions
Comparative, Randomized, 2-way Crossover Bioavailability Study of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules In Health Adult Males Under Fasted Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride capsules under fasted conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals) | |
| DRUG | Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel) |
Timeline
- Start date
- 1992-11-01
- Primary completion
- 1992-12-01
- Completion
- 1992-12-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913783. Inclusion in this directory is not an endorsement.